ICG coordinates PROGRESS, an international consortium funded by ERAPerMed


Very good news in these troubling times!!

 

 

We got wonderful news today. 

Our joint project "PROGRESS" will be funded!! 

This project is build on new and long-term collaborators. This will be very productive and a lot of fun! Looking forward doing some great research.

Here is a short abstract:

Coronary artery disease (CAD) is a major burden for patients and health care systems worldwide. The most common cause of CAD is atherosclerosis, an inflammatory disease gradually obstructing arteries, with life-threatening effects in the coronary circulation. Often, the circulation adapts through collateral artery formation, leading to significantly improved long-term post-ischemic outcome. Hence, timely determination of the collateral profile presents a pivotal factor in the Personalized Medicine of CAD. However, the coronary collateral circulation (CCC) development is not well predicted by traditional CAD risk factors. Moreover, manifold inconsistencies are still apparent in CCC research, mainly associated with the difficulty of quantifying CCC accurately and reproducibly. The overarching objective of PROGRESS is to develop a tool for more accurate, reproducible and automated prediction of patients’ potential to develop CCC, which could be used for a more efficient CAD patient management.

Comments